Digoxin assay: Results of 10 years of interlaboratory controls;Dosage de la digoxine: Exploitation de 10 ans de contrôles interlaboratoires

Annales de Biologie Clinique

Volumn 63, Issue 3, 2005, Pages 345-349

  Mandy, M ^a   Manchon, M ^a   Meley, R ^a   Eynard, J C ^a   Grafmeyer, D ^a  

^a Pro Bio Qual   (France)

Author keywords

Digoxin; Quality control

Indexed keywords

DIGOXIN;

ARTICLE; BLOOD; DIAGNOSIS, MEASUREMENT AND ANALYSIS; HUMAN; QUALITY CONTROL; STANDARD; TIME;

CLINICAL LABORATORY TECHNIQUES; DIGOXIN; HUMANS; QUALITY CONTROL; TIME FACTORS;

DIGITALIS;

EID: 20444458778     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Li-Saw-Hee FL, Lip GYH. Digoxin revisited. Q J Med 1998 ; 91 : 259-64.
2. Azzazy HM, Duh SH, Maturen A, et al. Multicenter study of abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. Clin Chem 1997 ; 43 : 1635-40.
3. Manchon M. Dosage des médicaments : la digoxine. Cahier de formation Bioforma 1997 ; 9 : 43-52.
4. Datta P, Dasgupta A. Interference of endogenous Digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer. Ther Drug Monit 2004 ; 26 : 85-9.
5. Steimer W, Müller C, Eber B. Digoxin assays: frequent substantial and potentially dangerous interference by spironolacton, canrenone and other steroids. Clin Chem 2002 ; 48 : 507-51.